NM_000191.3:c.109G>A
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PP2PP3_StrongPP5_Very_Strong
The NM_000191.3(HMGCL):c.109G>A(p.Glu37Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,822 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000191.3 missense
Scores
Clinical Significance
Conservation
Publications
- 3-hydroxy-3-methylglutaric aciduriaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Orphanet, Myriad Women’s Health, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000191.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| HMGCL | NM_000191.3 | MANE Select | c.109G>A | p.Glu37Lys | missense | Exon 2 of 9 | NP_000182.2 | ||
| HMGCL | NM_001166059.2 | c.109G>A | p.Glu37Lys | missense | Exon 2 of 7 | NP_001159531.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| HMGCL | ENST00000374490.8 | TSL:1 MANE Select | c.109G>A | p.Glu37Lys | missense | Exon 2 of 9 | ENSP00000363614.3 | ||
| HMGCL | ENST00000509389.5 | TSL:1 | n.121G>A | non_coding_transcript_exon | Exon 2 of 6 | ||||
| HMGCL | ENST00000436439.6 | TSL:2 | c.109G>A | p.Glu37Lys | missense | Exon 2 of 7 | ENSP00000389281.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461822Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 727218 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Deficiency of hydroxymethylglutaryl-CoA lyase Pathogenic:2
Variant summary: HMGCL c.109G>A (p.Glu37Lys) results in a conservative amino acid change located in the Pyruvate carboxyltransferase domain (IPR000891) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251488 control chromosomes. c.109G>A has been reported in the literature in two homozygous individuals in one family affected with HMG-CoA Lyase Deficiency (Menao_2009). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in more than 95% reduction in lysase activity in an in vitro biochemical assay (Menao_2009). The following publication have been ascertained in the context of this evaluation (PMID: 19177531). ClinVar contains an entry for this variant (Variation ID: 2676029). Based on the evidence outlined above, the variant was classified as pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at